ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Eloxx Pharmaceuticals (ELOX) Technical (Analysis) Reports Eloxx Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Eloxx Pharmaceuticals (ELOX)

Technical Analysis Report for NASDAQ stock ELOX Eloxx Pharmaceuticals. Dated: 18 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Commercial Physical Biological Resarch in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ELOX Eloxx Pharmaceuticals then click here. or read Experts views on Eloxx Pharmaceuticals or Forecast & share price targets of Eloxx Pharmaceuticals

Eloxx Pharmaceuticals Opened at 18.47 and Closed at: 18.25, which is -1.21% of previous session's close. It moved within a range of 16.50 and 18.47
The session was a Bearish session with an average volume of 38200, which is 26.96% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

Support for tomorrow is 16.39 and resistance for tomorrow is 18.36
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 17.01, 15.77 resistance for tomorrow's hourly charts is 18.98, 19.71

10 Day SMA for Eloxx Pharmaceuticals (ELOX) is 18.22 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Eloxx Pharmaceuticals (ELOX) is 16.14 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Eloxx Pharmaceuticals (ELOX) is 13.85 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 9.42 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Eloxx Pharmaceuticals is 7.7 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Eloxx Pharmaceuticals is at 16.14 and 200 DMA is at 7.7, while 50 DMA and 100 DMA are at 13.85 and 9.42 respectively

Eloxx Pharmaceuticals (ELOX) moving average of 20 SMA is at 16.14 and 20 EMA is at 16.59

Eloxx Pharmaceuticals (ELOX) moving average of 50 SMA is at 13.85 and 50 EMA is at 13.69

Eloxx Pharmaceuticals (ELOX) moving average of 100 SMA is at 9.42 and 100 EMA is at 11.04

Eloxx Pharmaceuticals (ELOX) moving average of 200 SMA is at 7.7 and 200 EMA is at 8.32

Eloxx Pharmaceuticals has performed better than Arbutus Biopharma in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Ac Immune in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Alkermes Plc in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Benitec Biopharma in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Pacira Pharmaceuticals in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Crinetics Pharmaceuticals in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Cue Biopharma in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Redhill Biopharma in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Solid Biosciences in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Sol Gel in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Sanofi in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Sarepta Therapeutics in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Guardant Health in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Icon Plc in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Iridex Corporation in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals has performed better than Irhythm Technologies in short term. Holding Eloxx Pharmaceuticals could be a better choice for now!

Eloxx Pharmaceuticals Technical analysis of indicators

Price action analysis of Eloxx Pharmaceuticals (ELOX) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for Eloxx Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Eloxx Pharmaceuticals in short term

Eloxx Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Eloxx Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Eloxx Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 18.16 and Eloxx Pharmaceuticals ELOX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Eloxx Pharmaceuticals ELOX stock. Volume based technical analysis of Eloxx Pharmaceuticals ELOX stock is negative.

Eloxx Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ELOX Eloxx Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ELOX Experts View which covers a lot of information including buying and selling signals

ELOX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Eloxx Pharmaceuticals or View Candle Stick Charts here

Chart Eloxx Pharmaceuticals (ELOX)  Technical (Analysis) Reports Eloxx Pharmaceuticals [

Videos related to: Eloxx Pharmaceuticals (ELOX) Technical (Analysis) Reports Eloxx Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Eloxx Pharmaceuticals (ELOX)  Technical (Analysis) Reports Eloxx Pharmaceuticals [

 

Back to top